Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Heterologous SARS-CoV-2 Vaccine Regimens (Argentina)
NCT04962906Phase 2Completed
- Sponsor
- Ministerio de Salud de la Ciudad de Buenos Aires
- Start
- Jul 2021
- Primary completion
- Aug 2021
- Modality
- Viral Vector Vaccines
- Countries
- 1
01
Overview
A Phase 2 trial of ChAdOx1 nCoV-19, BBIBP-CorV in coronavirus disease 2019 (COVID-19), sponsored by Ministerio de Salud de la Ciudad de Buenos Aires. Started Jul 2021; status: completed.
02
Drugs
ChAdOx1 nCoV-19BBIBP-CorV
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04962906.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04962906.